Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M176Revenue (TTM) $M4.5Net Margin (%)-1,664.0Altman Z-Score-3.0
Enterprise Value $M76.0EPS (TTM) $-1.2Operating Margin %-1,725.5Piotroski F-Score2
P/E(ttm)--Beneish M-Score10.5Pre-tax Margin (%)-1,663.9Higher ROA y-yN
Price/Book1.810-y EBITDA Growth Rate %-19.3Quick Ratio2.9Cash flow > EarningsY
Price/Sales36.95-y EBITDA Growth Rate %-0.6Current Ratio2.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-66.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-88.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M74.6ROIC % (ttm)-668.0Gross Margin Increase y-yN

Gurus Latest Trades with ARWR

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ARWR is held by these investors:



ARWR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GIVEN DOUGLAS BDirector 2016-10-14Sell12,000$6.72-64.43view
Myszkowski Kenneth AllenCFO 2016-08-23Sell20,000$8-70.13view
Myszkowski Kenneth AllenCFO 2016-08-23Sell20,000$8-70.13view
Myszkowski Kenneth AllenCFO 2015-12-30Sell23,347$6.13-61.01view
Lewis David L.Chief Scientific Officer 2015-01-05Sell15,000$8.01-70.16view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.32-62.18view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.32-62.18view
McKenney CharlesDirector 2014-10-01Sell2,500$14.7-83.74view
Lewis David L.Chief Scientific Officer 2014-09-30Sell15,000$15.02-84.09view
GIVEN DOUGLAS BDirector 2014-09-26Sell2,000$15.24-84.32view

Quarterly/Annual Reports about ARWR:

News about ARWR:

Articles On GuruFocus.com
Arrowhead Research Making Headway In The RNAi Therapy Platform Mar 09 2015 
Weekly CEO Buys Highlight: NRP, OPK, GAM, KEY, ARWR Oct 20 2014 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 10 2011 
Weekly CFO Buys Highlight: JAZZ, VRTB, ASTM, ARWR, CGX Sep 04 2010 
Arrowhead Research Corp. Reports Operating Results (10-Q) May 13 2010 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 11 2010 
Arrowhead Research Corp. Reports Operating Results (10-K) Dec 22 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) Aug 10 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) May 15 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 09 2009 

More From Other Websites
SBPH: 2016 Results Sustaining Continued HBV/STING Development Feb 27 2017
These 5 Stocks Under $10 Could Explode Higher Feb 16 2017
ARROWHEAD PHARMACEUTICALS, INC. Financials Feb 10 2017
Edited Transcript of ARWR earnings conference call or presentation 6-Feb-17 9:30pm GMT Feb 06 2017
ARROWHEAD PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 06 2017
Arrowhead Research reports 1Q loss Feb 06 2017
Arrowhead Research reports 1Q loss Feb 06 2017
Arrowhead Reports Fiscal 2017 First Quarter Results Feb 06 2017
Q1 2017 Arrowhead Pharmaceuticals Inc Earnings Release - After Market Close Feb 06 2017
Drug Approvals Expected to Rise as Trump Pledges to Speed Up Approval Process: Latest Reports on... Feb 01 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results Jan 30 2017
Robbins Arroyo LLP: Arrowhead Pharmaceuticals, Inc. (ARWR) Misled Shareholders According to a... Jan 20 2017
IMPORTANT ARWR SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit... Jan 14 2017
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Arrowhead... Jan 13 2017
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Arrowhead Pharmaceuticals, Inc. of... Jan 13 2017
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead... Jan 12 2017
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Jan 12 2017
These 3 Biotech Stocks Are Already Moving Wildly on Thursday Jan 12 2017
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead... Jan 10 2017
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Arrowhead Pharmaceuticals, Inc. of a... Jan 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)